MariMed files proxy for Oct 28 special meeting to approve 1-for-50 to 1-for-100 reverse split

MARIMED INC.

Special meeting set for Oct 28, 2026 at 9:30 am ET; record date Sept 4, 2026 for voting.
Board authorized to execute reverse split at ratio between 1-for-50 and 1-for-100, at its discretion.
Purpose: meet minimum share price requirements for potential listing on U.S. national exchange.
No fractional shares; cash payment for fractional interests if split implemented.
CEO Jon Levine: listing on major exchange could broaden investor base and improve capital markets access.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.